Atlantic Health Sciences Corporation-Saint John Regional Hospital

Summary

Atlantic Health Sciences Corporation-Saint John Regional Hospital is a medical facility located in SAINT JOHN, New Brunswick. This center is recognized for care of Breast Cancer, Breast cancer, Colon Cancer, Ductal Carcinoma In Situ, Prostate Cancer and other specialties. Atlantic Health Sciences Corporation-Saint John Regional Hospital is involved with conducting 28 clinical trials across 30 conditions. There are 6 research doctors associated with this hospital, such as Farah Naz, Anthony J. Reiman, James Michael, and Alfonso Rivera Duarte.

Top PIs

Clinical Trials running at Atlantic Health Sciences Corporation-Saint John Regional Hospital

Breast Cancer

Small Cell Lung Cancer

Prostate Cancer

Prostate Adenocarcinoma

Breast cancer

Chronic Lymphocytic Leukemia

Colon Cancer

Lymphoma

Omitting Radiation Therapy

for Breast Cancer

The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.

Recruiting

2 awards

Phase 3

19 criteria

Pembrolizumab

for Triple-Negative Breast Cancer

The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.

Recruiting

2 awards

Phase 3

19 criteria

Hormone Therapy with or without Radiation

for Breast Cancer

This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.

Recruiting

2 awards

Phase 3

13 criteria